Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii
about
Why prevent, diagnose and treat congenital toxoplasmosis?Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects.Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review.Diagnosis of parasitic diseases: old and new approachesEvaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse modelMaternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.Multicentric comparative analytical performance study for molecular detection of low amounts of Toxoplasma gondii from simulated specimensEpidemiology of and diagnostic strategies for toxoplasmosisGenotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis.Characterization and multicentric validation of a common standard for Toxoplasma gondii detection using nucleic acid amplification assays.Prospective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methodsStrain hypothesis of Toxoplasma gondii infection on the outcome of human diseases.A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR.Recent developments for diagnosis of toxoplasmosis.Severe Toxoplasma gondii I/III recombinant-genotype encephalitis in a human immunodeficiency virus patient.Novel interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at the time of maternal infectionComparative assessment of a commercial kit and two laboratory-developed PCR assays for molecular diagnosis of congenital toxoplasmosisPrenatal and Early Postnatal Diagnosis of Congenital Toxoplasmosis in a Setting With No Systematic Screening in Pregnancy.Prevention and treatment of congenital toxoplasmosis.Behavioral Abnormalities in a Mouse Model of Chronic Toxoplasmosis Are Associated with MAG1 Antibody Levels and Cyst Burden.HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosisManagement of Toxoplasma gondii infection during pregnancy.Polymerase chain reaction in the diagnosis of congenital toxoplasmosis: more than two decades of development and evaluation.EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system.Diagnosis of parasitic infections: what's going on?Severe congenital toxoplasmosis: a case report and strain characterization.Real-time PCR as a prognostic tool for human congenital toxoplasmosis.Evaluation of Toxoplasma ELITe MGB Real-Time PCR Assay for Diagnosis of Toxoplasmosis.Anti-Toxoplasma gondii antibodies in pregnant women and their newborn infants in the region of São José do Rio Preto, São Paulo, Brazil.Surveillance and monitoring of Toxoplasma in humans, food and animals - Scientific Opinion of the Panel on Biological HazardsIsothermal PCR for Feasible Molecular Diagnosis of Primary Toxoplasmosis in Women Recently Experienced Spontaneous Abortion.Large Scale Pre-Diagnosis of Toxoplasma Gondii DNA Genotyping by Real-Time PCR on Amniotic Fluid
P2860
Q22305913-36B795E3-5A67-431D-9E17-8349515B22A6Q29353941-12638904-90EB-4781-A06D-9D92540A4D63Q30251427-47A90FC0-DA64-4725-8508-469C13952593Q33580745-34EBE585-FCF4-4A3F-80C5-EF24BDE7E10CQ33827792-4647D226-E1A3-409B-877C-ED2A8A1EBB00Q34043532-4E109FF9-EAF7-4880-84F1-CCCB2D353250Q34120562-A86F8C45-DB46-48E8-8860-28F46F6B10A2Q34267180-5A28AED4-AA4B-46D6-A76D-7DE857CE13FBQ34569242-B3C5DFEC-3256-4562-822F-88569EA92095Q35035984-D10FF764-3F99-415D-8C96-160CE7D2E189Q35140104-53CEC4E9-ABE0-47A4-8992-EE0441C0082BQ35181148-407BE2DC-9FEB-4269-9226-D9BFF8E3EBCAQ35193272-327D9AA2-E0B5-4C32-AA04-D38CDC0DCB71Q35683730-0F44AA8F-7FF4-43FB-8700-B937472B5366Q36098557-3D77EBFB-2477-4337-B923-74FE633662FCQ36413941-F6ED2324-3C8D-4E96-9E7F-FC29D5D9F66AQ36414143-5A119C0A-9952-492A-A50A-A7FE43B7A2CCQ36664083-817B71CA-6F49-44F6-94FA-FFE71D8EB159Q36777857-C6724E35-05AA-414E-A410-F1A3725A7CA8Q36849027-E82EB2E0-0059-4963-86BE-C0DFC5D514EEQ36913323-A881FBDA-D7B2-4CFC-963E-2E743519561AQ37215176-00B7B87E-F79A-4697-A7F3-C6C27FB87104Q37827381-FAA14985-C305-45D8-A57F-F25EEB4130EEQ38033652-0E4A37A5-A974-4F1C-BD45-C94C8AA171F1Q38244508-D6CA3CB8-D7F3-4D81-BD99-A00B1F47EAF2Q41481588-F2C98156-1C2B-4ECC-8137-27FB20CB0830Q41983123-A25CE895-8621-4077-B1EA-AE2CCBDE6AA1Q43107519-04C746F0-8756-412D-B253-6BF5E9A45889Q44667303-FC1C1FF8-5F0D-495B-972F-65276E86BB72Q47145110-C395F79D-F014-4409-86C5-48C80431C28CQ55452290-A8B3790F-A1A6-4F68-BC49-53CAC4E9A5B2Q59200084-F38A160A-E910-48FE-8F8D-746A1D8F4C8F
P2860
Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii
description
im März 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2004
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2004
@uk
name
Usefulness of quantitative pol ...... fection with Toxoplasma gondii
@en
Usefulness of quantitative pol ...... fection with Toxoplasma gondii
@nl
type
label
Usefulness of quantitative pol ...... fection with Toxoplasma gondii
@en
Usefulness of quantitative pol ...... fection with Toxoplasma gondii
@nl
prefLabel
Usefulness of quantitative pol ...... fection with Toxoplasma gondii
@en
Usefulness of quantitative pol ...... fection with Toxoplasma gondii
@nl
P2093
P1476
Usefulness of quantitative pol ...... fection with Toxoplasma gondii
@en
P2093
François Kieffer
François Peyron
Henri Dumon
Jacqueline Franck
Karine Kaiser
Martine Wallon
Muriel Chosson
Philippe Thulliez
Stéphane Romand
P304
P356
10.1016/J.AJOG.2003.09.039
P407
P577
2004-03-01T00:00:00Z